210 related articles for article (PubMed ID: 19143966)
21. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
[TBL] [Abstract][Full Text] [Related]
22. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation.
Chen HS; Ho MC; Hu RH; Wu JF; Chen HL; Ni YH; Hsu HY; Jeng YM; Chang MH
J Formos Med Assoc; 2019 Sep; 118(9):1362-1368. PubMed ID: 30612881
[TBL] [Abstract][Full Text] [Related]
23. Patients at risk for development of posttransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction.
Wagner HJ; Wessel M; Jabs W; Smets F; Fischer L; Offner G; Bucsky P
Transplantation; 2001 Sep; 72(6):1012-9. PubMed ID: 11579293
[TBL] [Abstract][Full Text] [Related]
24. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
Shapiro NL; Tang CG; Bhattacharyya N
Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
[TBL] [Abstract][Full Text] [Related]
25. Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation.
Matsukura T; Yokoi A; Egawa H; Kudo T; Kawashima M; Hirata Y; Tanaka H; Kagajo K; Wada H; Tanaka K
Clin Transplant; 2002 Apr; 16(2):107-12. PubMed ID: 11966780
[TBL] [Abstract][Full Text] [Related]
26. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
[TBL] [Abstract][Full Text] [Related]
27. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
D'Antiga L; Del Rizzo M; Mengoli C; Cillo U; Guariso G; Zancan L
Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
[TBL] [Abstract][Full Text] [Related]
28. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
Orii T; Ohkohchi N; Satomi S; Hoshino Y; Kimura H
Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr viremia levels after pediatric liver transplantation as measured by real-time polymerase chain reaction.
Kullberg-Lindh C; Ascher H; Saalman R; Olausson M; Lindh M
Pediatr Transplant; 2006 Feb; 10(1):83-9. PubMed ID: 16499593
[TBL] [Abstract][Full Text] [Related]
30. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
Yancoski J; Danielian S; Ibañez J; Turconi A; Cuarterolo M; Zelazko M; Niesters Hubert GM
J Clin Virol; 2004 Sep; 31(1):58-65. PubMed ID: 15288615
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
32. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
[TBL] [Abstract][Full Text] [Related]
33. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
Jabs WJ; Hennig H; Kittel M; Pethig K; Smets F; Bucsky P; Kirchner H; Wagner HJ
J Clin Microbiol; 2001 Feb; 39(2):564-9. PubMed ID: 11158107
[TBL] [Abstract][Full Text] [Related]
34. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
Lee TC; Goss JA; Rooney CM; Heslop HE; Barshes NR; Caldwell YM; Gee AP; Scott JD; Savoldo B
Clin Transplant; 2006; 20(6):689-94. PubMed ID: 17100717
[TBL] [Abstract][Full Text] [Related]
35. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K
Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting chronic high load carriage of Epstein-Barr virus is more common in young pediatric renal transplant recipients.
Ladfors SW; Lindahl JK; Hansson S; Brandström P; Andersson R; Jertborn M; Lindh M; Woxenius S; Friman V
Pediatr Nephrol; 2020 Mar; 35(3):427-439. PubMed ID: 31802220
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.
Höcker B; Fickenscher H; Delecluse HJ; Böhm S; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Billing H; Fichtner A; Feneberg R; Sander A; Köpf-Shakib S; Süsal C; Tönshoff B
Clin Infect Dis; 2013 Jan; 56(1):84-92. PubMed ID: 23042966
[TBL] [Abstract][Full Text] [Related]
38. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
Michelson P; Watkins B; Webber SA; Wadowsky R; Michaels MG
Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study.
Parrish A; Fenchel M; Storch GA; Buller R; Mason S; Williams N; Ikle D; Conrad C; Faro A; Goldfarb S; Hayes D; Melicoff-Portillo E; Schecter M; Visner G; Sweet S; Danziger-Isakov L;
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28639398
[TBL] [Abstract][Full Text] [Related]
40. Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients.
Baldanti F; Rognoni V; Cascina A; Oggionni T; Tinelli C; Meloni F
Virol J; 2011 Sep; 8():421. PubMed ID: 21892950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
